Vol 72, No 1 (2021)
Clinical vignette
Published online: 2020-12-08
A combination of plasma exchange and steroids in the treatment of a-lipoic acid-induced insulin autoimmune syndrome
Abstract
Not required for Clinical Vignette.
Keywords: insulin autoimmune syndromealpha lipoic acidhypoglycaemia
References
- Uchigata Y, Hirata Y. Insulin autoimmune syndrome (IAS, Hirata disease). Ann Med Interne (Paris). 1999; 150(3): 245–253.
- Takeuchi Y, Miyamoto T, Kakizawa T, et al. Insulin Autoimmune Syndrome possibly caused by alpha lipoic acid. Intern Med. 2007; 46(5): 237–239.
- Uchigata Y, Hirata Y, Omori Y, et al. Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Hum Immunol. 2000; 61(2): 154–157.
- Chu JP, Zheng XW, Lu J, et al. Insulin-induced autoimmune syndrome: A case report. Exp Ther Med. 2016; 12(5): 3359–3362.
- Saxon DR, McDermott MT, Michels AW. Novel Management of Insulin Autoimmune Syndrome with Rituximab and Continuous Glucose Monitoring. J Clin Endocrinol Metab. 2016; 101(5): 1931–1934.
